| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.043 | 0.5 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.5 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | 0.038 | 0.5 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | -0.089 | 0.5 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |